Deka Bank Deutsche Girozentrale Lexicon Pharmaceuticals, Inc. Transaction History

Deka Bank Deutsche Girozentrale

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$1.2 - $6.66 $91,538 - $508,038	-76,282 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$5.35 - $7.11 $172,050 - $228,650	-32,159 Reduced 29.66%	76,282 $465,000
Q1 2019 May 10, 2019	BUY	$4.36 - $7.94 $113,455 - $206,614	26,022 Added 31.57%	108,441 $1.27 Million
Q4 2018 Feb 12, 2019	SELL	$6.15 - $10.51 $160,035 - $273,491	-26,022 Reduced 24.0%	82,419 $528,000
Q3 2018 Nov 09, 2018	SELL	$10.32 - $13.06 $10,320 - $13,060	-1,000 Reduced 0.91%	108,441 $0
Q2 2018 Aug 14, 2018	BUY	$7.8 - $13.69 $15,600 - $27,380	2,000 Added 1.86%	109,441 $1.36 Million
Q1 2018 May 03, 2018	SELL	$7.86 - $11.39 $282,960 - $410,040	-36,000 Reduced 25.1%	107,441 $899,000
Q3 2017 Nov 06, 2017	BUY	$12.17 - $16.3 $1.75 Million - $2.34 Million	143,441	143,441 $2.08 Million

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.